16482646

Source:http://linkedlifedata.com/resource/pubmed/id/16482646

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:16482646	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:16482646	lifeskim:mentions	umls-concept:C0003873	lld:lifeskim
pubmed-article:16482646	lifeskim:mentions	umls-concept:C0013072	lld:lifeskim
pubmed-article:16482646	lifeskim:mentions	umls-concept:C0034656	lld:lifeskim
pubmed-article:16482646	lifeskim:mentions	umls-concept:C0178602	lld:lifeskim
pubmed-article:16482646	lifeskim:mentions	umls-concept:C0205177	lld:lifeskim
pubmed-article:16482646	lifeskim:mentions	umls-concept:C0717758	lld:lifeskim
pubmed-article:16482646	lifeskim:mentions	umls-concept:C1707455	lld:lifeskim
pubmed-article:16482646	pubmed:issue	4	lld:pubmed
pubmed-article:16482646	pubmed:dateCreated	2006-4-3	lld:pubmed
pubmed-article:16482646	pubmed:abstractText	To assess the safety and efficacy of etanercept 50 mg administered twice weekly versus 25 mg administered twice weekly as monotherapy in patients with tumor necrosis factor-alpha (TNF-alpha) blocker-naäve active rheumatoid arthritis (RA).	lld:pubmed
pubmed-article:16482646	pubmed:language	eng	lld:pubmed
pubmed-article:16482646	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16482646	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:16482646	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16482646	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16482646	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16482646	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16482646	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:16482646	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:16482646	pubmed:month	Apr	lld:pubmed
pubmed-article:16482646	pubmed:issn	0315-162X	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:WeinblattMich...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:MorelandLarry...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:CoblynJonatha...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:MeasePhilip...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:HelfgottSimon...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:SchiffMichael...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:MaierAgnes...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:LeffJonathan...	lld:pubmed
pubmed-article:16482646	pubmed:author	pubmed-author:JohnsenAlyssa...	lld:pubmed
pubmed-article:16482646	pubmed:issnType	Print	lld:pubmed
pubmed-article:16482646	pubmed:volume	33	lld:pubmed
pubmed-article:16482646	pubmed:owner	NLM	lld:pubmed
pubmed-article:16482646	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:16482646	pubmed:pagination	659-64	lld:pubmed
pubmed-article:16482646	pubmed:dateRevised	2006-11-15	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:meshHeading	pubmed-meshheading:16482646...	lld:pubmed
pubmed-article:16482646	pubmed:year	2006	lld:pubmed
pubmed-article:16482646	pubmed:articleTitle	Comparison of 2 doses of etanercept (50 vs 100 mg) in active rheumatoid arthritis: a randomized double blind study.	lld:pubmed
pubmed-article:16482646	pubmed:affiliation	Division of Rheumatology, Immunology, and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.	lld:pubmed
pubmed-article:16482646	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:16482646	pubmed:publicationType	Comparative Study	lld:pubmed
pubmed-article:16482646	pubmed:publicationType	Randomized Controlled Trial	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16482646	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:16482646	lld:pubmed